Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Pamidronate Disodium products are in shortage in Canada (1 of 7 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A bisphosphonate used to treat high blood calcium and bone conditions.
Products affected
1 / 7
In shortage since
Jan 1, 2013
Reports on file
10
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
PAMIDRONATE DISODIUM OMEGA 3 MG/ML
3.0MG · SOLUTION · OMEGA LABORATORIES LTD
DIN 02249669 · since Jan 1, 2013, no end estimate · Disruption of the manufacture of the drug.
Resolved
PAMIDRONATE DISODIUM OMEGA 9 MG/ML
9MG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 02249685 · ended Oct 15, 2025 · Disruption of the manufacture of the drug.
Resolved
PAMIDRONATE DISODIUM FOR INJECTION
9MG · SOLUTION · PFIZER CANADA ULC
DIN 02244552 · ended Apr 30, 2024 · Disruption of the manufacture of the drug.
Resolved
PAMIDRONATE DISODIUM OMEGA 9 MG/ML
9.0MG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 02249685 · ended Feb 12, 2024 · Disruption of the manufacture of the drug.
Resolved
PAMIDRONATE DISODIUM FOR INJECTION
6MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02246598 · ended May 1, 2023 · Disruption of the manufacture of the drug.
Resolved
PAMIDRONATE DISODIUM OMEGA 9 MG/ML
9.0MG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 02249685 · ended May 9, 2023 · Demand increase for the drug.
Resolved
PAMIDRONATE DISODIUM FOR INJECTION
9MG · SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02246599 · ended Mar 31, 2023 · Product is on 100% allocation.
Resolved
PAMIDRONATE DISODIUM FOR INJECTION
6MG · SOLUTION · PFIZER CANADA ULC
DIN 02244551 · ended Dec 13, 2021 · Disruption of the manufacture of the drug.
Resolved
PAMIDRONATE DISODIUM FOR INJECTION
3MG · SOLUTION · PFIZER CANADA ULC
DIN 02244550 · ended Jul 13, 2020 · Delay in shipping of the drug.
Resolved
PAMIDRONATE DISODIUM FOR INJECTION
9MG · SOLUTION · PFIZER CANADA ULC
DIN 02244552 · ended Aug 26, 2019 · Disruption of the manufacture of the drug.
What's happening
Pamidronate Disodium is currently affected by an active shortage report filed with Health Canada by OMEGA LABORATORIES LTD.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Pamidronate Disodium is classified under “DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION” (ATC M05BA).
Recent changes
No changes recorded yet.
Common questions
What is Pamidronate Disodium used for?
A bisphosphonate used to treat high blood calcium and bone conditions.
When will Pamidronate Disodium be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Pamidronate Disodium in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.